Dubai Derma 2025 took place from April 14-16 at the Dubai World Trade Centre, attracting over 700 brands and more than 25,000 professional attendees. Our two flagship brands, ENZOEYS and CIELLULU, participated in the exhibition, showcasing the super photorejuvenation product series. The event resulted in preliminary partnership agreements with agents from over 30 countries. Looking forward, ENZOEYS will deepen global collaboration to jointly expand the aesthetic medicine market.

In February 2025, ENZOEYS and Japan Zeus Corporation signed a strategic cooperation agreement in Guangzhou, with a South Korean company participating as technical co-organizer. Senior executives from both parties attended the ceremony. This partnership marks the successful passage of the ENZOEYS brand RUIKD through Japanese stringent market certification, paving the way for in-depth collaboration in technological innovation and […]

From August 6–7, 2025, ENZOEYS showcased its latest aesthetic technologies at the 4th Malaysia International Aesthetic Medicine Conference (AMSC) in Kuala Lumpur. Star devices including the FDA-certified MULA K2, SuperTouch S500, and LIFFAN Q6 drew strong attention from global professionals. Through in-depth discussions with doctors and distributors, ENZOEYS strengthened its international presence and demonstrated leadership in energy-based skincare innovation. Guided by its mission — “Innovation with Integrity, Technology for Wellness” — ENZOEYS remains committed to advancing the global aesthetic industry with smarter and safer solutions.

The 13th Chinese Conference of Laser Cosmetic Therapy and Facial Rejuvenation (CCLR) was held in Shanghai from April 17-20, 2025. ENZOEYS unveiled its innovative products at the event, highlighting semiconductor-based dual-effect skin rejuvenation solutions featuring three core technological breakthroughs. Its flagship products, including Mura K2 and SuperTouch S500, attracted significant attention. The solution aligns with life cosmetology and medical cosmetology evolution. Our exhibitors also discussed with experts on industry topics, proving the corporate philosophy of Technology Drives Beauty Industry Evolution.

In April 2025, ENZOEYS obtained its Class II Medical Device Manufacturing License, establishing itself as a nationally certified manufacturer of high-end medical aesthetics equipment. This stringently reviewed qualification validates the company's robust technological and quality capabilities. Founded in 1986, ENZOEYS holds over 100 patents with products exported globally. Following license approval, ENZOEYS upgraded its full product lifecycle management system. Looking ahead, ENZOEYS will launch five new products as part of its transformation strategy, setting a benchmark for industry development.